Daniel Farraye

Daniel Farraye

Goodwin

Contact
View Bio
RSS

Latest Posts › Eli Lilly

Share:

Eli Lilly Files Suit Challenging the FDA’s Drug Classification of Retatrutide

​​​​​​​On September 3, 2024, Eli Lilly filed a complaint against the FDA in the District Court for the Southern District of Indiana pursuing the latest challenge to the FDA’s application of its “biological product”...more

9/25/2024  /  Eli Lilly , Food and Drug Administration (FDA) , Intellectual Property Litigation , Pharmaceutical Industry , PHSA , Prescription Drugs
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide